跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Vomivert - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Vomivert
Approved
STANDARD
Vomivert
Windlas Biotech Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4a242ba6fa4a39e6
Company
Windlas Biotech Limited
Type
Standard
Approval Details
Approval Id
4a242ba6fa4a39e6
Drug Approval Philippines Name
Vomivert
Product Name
Vomivert
Registration Number
DRP-5644-02
Brand Name
Vomivert
Generic Name
Betahistine Hydrochloride
Dosage Form
Dispersible Tablet
Dosage Strength
24 mg
Manufacturer
Windlas Biotech Limited
Importer
Ambica International Corporation
Distributor
Diafarm Inc.
Company Detail Path
/organization/windlas-biotech-limited
Issuance Date
20 October 2024
Expiry Date
29 July 2030
Pharmacologic Category
Antivertigo
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4a242ba6fa4a39e6
Type
Standard
Back to Philippines FDA Approvals